GGrantIndex
Sort

146,196 grants matching diabetes

NOURISH: A healthcare-community partnership to improve nutrition insecurity for optimal glycemic control and pregnancy outcomes with pregestational diabetes

$733,679
Kartik Kailas Venkatesh · Ohio State University · R01 · FY2025 · NR

Molecular mechanisms of signaling systems responsive to light, redox and chemical environment

$733,651
Brian R Crane · Cornell University · R35 · FY2023 · GM

REPOSITORY SERVICES FOR WOMENS INTERAGENCY HIV STUDY (WIHS) STAR SPECIAL TREATMENT AND RESEARCH (STAR)

$733,604
Brittany Martin · Fisher Bioservices, Inc. · N01 · FY2022 · HD

Genomic Background of Blood Pressure Response to Thiazide Diuretic in African Americans

$733,590
Marguerite R Irvin · University Of Alabama At Birmingham · R01 · FY2017 · HL

HIV HCV Coinfection Antiviral Therapy and Fibrosis

$733,577
David L Thomas · Johns Hopkins University · R37 · FY2015 · DA

HIV HCV Coinfection Antiviral Therapy and Fibrosis

$733,577
David L Thomas · Johns Hopkins University · R37 · FY2019 · DA

HIV HCV Coinfection Antiviral Therapy and Fibrosis

$733,577
David L Thomas · Johns Hopkins University · R37 · FY2017 · DA

Paternal Contributions to Metabolic Disease in Offspring: Environment, Epigenetics, and Sperm

$733,550
Mary E Patti · Joslin Diabetes Center · R01 · FY2023 · DK

The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease

$733,538
Kyung W Lee · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DK

Discovery of novel environmental chemicals in a diverse population of maternal-infant pairs

$733,509
Tracey J. Woodruff · University Of California, San Francisco · R01 · FY2020 · ES

Pathogenesis of youth onset pre-diabetes and Type 2 diabetes

$733,481
Sonia Caprio · Yale University · R01 · FY2024 · DK

OPA1 an Estrogen-Mediated Modulator of Platelet Hyperactivation

$733,453
Evan Dale Abel · University Of California Los Angeles · R33 · FY2022 · HL

CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D

$733,450
Nora E Sarvetnick · University Of Nebraska Medical Center · R01 · FY2020 · AI

Prevention of Hepatocellular Carcinoma (HCC) Associated with Non-Alcoholic Steatohepatitis (NASH)

$733,441
Laura Beretta · University Of Tx Md Anderson Can Ctr · N01 · FY2018 · CA

Action for Health in Diabetes Continuation (Look AHEAD)

$733,400
Robert W Jeffery · University Of Minnesota · U01 · FY2013 · DK

Immunologic, Inflammatory, and Clinical contributors to HIV-Related Heart Failure with Preserved Ejection Fraction (HFpEF)

$733,395
Matthew Joel Feinstein · Northwestern University At Chicago · R01 · FY2023 · HL

Delineating mechanisms of skeletal fragility in older adults with Type 1 Diabetes

$733,381
Elaine Wei-Yin Yu · Massachusetts General Hospital · R01 · FY2021 · DK

Genetics of Diabetic Retinopathy in Hispanics

$733,346
Jerome I. Rotter · Cedars-Sinai Medical Center · R01 · FY2009 · EY

Portable hand-held non-mydriatic retinal camera

$733,346
Peter N Soliz · Visionquest Biomedical, Llc · R44 · FY2015 · EY

Resolution of inflammation and atrial fibrillation

$733,325
Samuel C Dudley · University Of Minnesota · R01 · FY2023 · HL

The University of Arizona Wound Care Center Clinical Research Unit

$733,314
Geoffrey C Gurtner · University Of Arizona · U01 · FY2024 · DK

Development of marmoset models of neurodegenerative disease using embryonic stem cell-based gene-editing approaches

$733,301
Kuo-Fen Lee · Salk Institute For Biological Studies · R24 · FY2020 · OD

Comparative Effectiveness of Carotid Artery Revascularization vs Medical Therapy

$733,294
Salomeh Keyhani · Northern California Institute/Res/Edu · R01 · FY2014 · HL

Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States

$733,285
Xuehong Zhang · Yale University · U01 · FY2025 · CA

Power-Up: An Effectiveness Trial of the Diabetes Prevention Program Tailored for Black and Latino Men

$733,278
Earle C Chambers · Albert Einstein College Of Medicine · R01 · FY2023 · DK